|
1
|
Sawada T, Akashi S, Nakamura S, Kuwayama
T, Enokido K, Yoshida M, Hashimoto R, Ide T, Masuda H, Taruno K, et
al: Digital volumetric measurement of mammographic density and the
risk of overlooking cancer in Japanese women. Breast Cancer.
24:708–713. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Göhler S, Da Silva Filho MI, Johansson R,
Enquist-Olsson K, Henriksson R, Hemminki K, Lenner P and Försti A:
Functional germline variants in driver genes of breast cancer.
Cancer Causes Control. 28:259–271. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Melgaard D: What is the effect of treating
secondary lymphedema after breast cancer with complete decongestive
physiotherapy when the bandage is replaced with Kinesio Textape? -
A pilot study. Physiother Theory Pract. 32:446–451. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yao L, Chi Y, Hu X, Li S, Qiao F, Wu J and
Shao ZM: Elevated expression of RNA methyltransferase BCDIN3D
predicts poor prognosis in breast cancer. Oncotarget.
7:53895–53902. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wei D, Zhang P, Zhou M, Feng Y and Chen Q:
HMGN2 protein inhibits the growth of infected T24 cells in vitro. J
Cancer Res Ther. 10:299–304. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hewson C, Capraro D, Burdach J, Whitaker N
and Morris KV: Nuclear protein HMGN2 attenuates pyocyanin-induced
oxidative stress via Nrf2 signaling and inhibits Pseudomonas
aeruginosa internalization in A549 cells. Free Radic Biol Med.
3:87–96. 2016.
|
|
7
|
Hu A, Dong X, Liu X, Zhang P, Zhang Y, Su
N, Chen Q and Feng Y: Nucleosome-binding protein HMGN2 exhibits
antitumor activity in oral squamous cell carcinoma. Oncol Lett.
7:115–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dong X, Liu X, Zhang Y, Zhang P, Lu L, Li
X, Huang P and Feng Y: Study on prohibition of high mobility group
chromosomal protein N2 against human oral squamous cell carcinoma
in vitro. Hua Xi Kou Qiang Yi Xue Za Zhi. 31:91–95. 2013.(In
Chinese). PubMed/NCBI
|
|
9
|
Saito A, Suzuki HI, Horie M, Ohshima M,
Morishita Y, Abiko Y and Nagase T: An integrated expression
profiling reveals target genes of TGF-β and TNF-α possibly mediated
by microRNAs in lung cancer cells. PLoS One. 9:335–349. 2014.
View Article : Google Scholar
|
|
10
|
Kanagesan S, Aziz SB, Hashim M, Ismail I,
Tamilselvan S, Alitheen NB, Swamy MK, Purna Chandra and Rao B:
Synthesis, characterization and in vitro evaluation of manganese
ferrite (MnFe2O4) nanoparticles for their biocompatibility with
murine breast cancer cells (4T1). Molecules. 21:3122016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Haricharan S, Lei J and Ellis M: Mammary
ductal environment is necessary for faithful maintenance of
estrogen signaling in ER+ breast cancer. Cancer Cell.
29:249–250. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qiao G, Cong Y, Zou H, Lin J, Wang X, Li
X, Li Y and Zhu S: False-negative frozen section of sentinel lymph
node biopsy in a Chinese population with breast cancer. Anticancer
Res. 36:1331–1337. 2016.PubMed/NCBI
|
|
13
|
Wu J, Kim S, Kwak MS, Jeong JB, Min HJ,
Yoon HG, Ahn JH and Shin JS: High mobility group nucleosomal
binding domain 2 (HMGN2) SUMOylation by the SUMO E3 ligase PIAS1
decreases the binding affinity to nucleosome core particles. J Biol
Chem. 289:20000–20011. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schauwecker SM, Kim JJ, Licht JD and
Clevenger CV: Histone H1 and chromosomal protein HMGN2 regulate
prolactin-induced STAT5 transcription factor recruitment and
function in breast cancer cells. J Biol Chem. 297:15–20. 2016.
|
|
15
|
Shimahara H, Hirano T, Ohya K, Matsuta S,
Seeram SS and Tate S: Nucleosome structural changes induced by
binding of non-histone chromosomal proteins HMGN1 and HMGN2. FEBS
Open Bio. 3:184–191. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kulkeaw K, Inoue T, Mizuochi C, Horio Y,
Ishihama Y and Sugiyama D: Ectopic expression of Hmgn2 antagonizes
mouse erythroid differentiation in vitro. Cell Biol Int.
36:195–202. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu G, Cao Y, Fan B, Zheng F, Gao X, Liu N,
Liu X and Huang N: High-mobility group protein N2 (HMGN2) inhibited
the internalization of Klebsiella pneumoniae into cultured bladder
epithelial cells. Acta Biochim Biophys Sin (Shanghai). 43:680–687.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Musselman CA and Kutateladze TG: Methyl
fingerprinting of the nucleosome reveals the molecular mechanism of
high-mobility group nucleosomal-2 (HMGN2) association. Proc Natl
Acad Sci USA. 108:12189–12190. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dal Cin P, Fusco A, Belge G, Chiappetta G,
Fedele M, Pauwels P, Bullerdiek J and Van den Berghe H: Involvement
of the HMGI(Y) gene in a microfollicular adenoma of the thyroid.
Genes Chromosomes Cancer. 24:286–289. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Subramanian M, Gonzalez RW, Patil H, Ueda
T, Lim JH, Kraemer KH, Bustin M and Bergel M: The
nucleosome-binding protein HMGN2 modulates global genome repair.
FEBS J. 276:6646–6657. 2009. View Article : Google Scholar : PubMed/NCBI
|
